Lu Chen
Impact in
- Immunology top 1%
- interferon and immune responses
- Immune cells in cancer
- Immune Response and Inflammation
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 13
- Extracellular vesicles in disease 11
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 7
- Immunology 46
- Immune cells in cancer 17
- IL-33, ST2, and ILC Pathways 7
- Co-authors
- Xiang Zhou (2 shared papers)Zhengfan Jiang (2 shared papers)Wenxiang Sun (2 shared papers)Fuping You (2 shared papers)Huihui Chen (1 shared paper)Yang Li (1 shared paper)Yi Zhou (1 shared paper)Zhonghe Zhai (1 shared paper)
- Journals
- The Journal of Immunology (4 papers)Cell Death and Disease (4 papers)Frontiers in Immunology (3 papers)Oncotarget (3 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lu Chen
116 papers receiving 4.8k citations
Lu Chen's Hit Papers
Peers
Comparison fields: 5 of 123
- Immunology 1.9k
- Cancer Research 1.1k
- Molecular Biology 2.5k
- Infectious Diseases 498
- Oncology 677
Countries citing papers authored by Lu Chen
This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).
Fields of papers citing papers by Lu Chen
This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization Hit paper breakdown → | 2009 | 712 |
| 2 | 2012 | 381 | |
| 3 | Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities Hit paper breakdown → | 2019 | 328 |
| 4 | 2011 | 299 | |
| 5 | 2017 | 195 | |
| 6 | Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis Hit paper breakdown → | 2022 | 157 |
| 7 | 2008 | 146 | |
| 8 | 2020 | 143 | |
| 9 | 2019 | 127 | |
| 10 | 2020 | 113 | |
| 11 | 2021 | 102 | |
| 12 | 2021 | 80 | |
| 13 | 2022 | 80 | |
| 14 | 2019 | 73 | |
| 15 | 2011 | 70 | |
| 16 | 2022 | 69 | |
| 17 | 2021 | 68 | |
| 18 | 2023 | 66 | |
| 19 | 2002 | 64 | |
| 20 | 2019 | 62 |
About Lu Chen
Lu Chen is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Public Health, Environmental and Occupational Health, having authored 126 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immune cells in cancer (17 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (13 papers), MicroRNA in disease regulation (12 papers), Extracellular vesicles in disease (11 papers), RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (7 papers) and IL-33, ST2, and ILC Pathways (7 papers). The work is most often cited by research in Immunology (1.9k citations), Cancer Research (1.1k citations), Molecular Biology (2.5k citations), Infectious Diseases (498 citations) and Oncology (677 citations). Lu Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiang Zhou, Zhengfan Jiang, Wenxiang Sun, Fuping You, Huihui Chen, Yang Li, Yi Zhou, Zhonghe Zhai, Danying Chen and Dawei Rong. Their work appears in journals such as The Journal of Immunology, Cell Death and Disease, Frontiers in Immunology, Oncotarget and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.